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AbstrACt
Objectives To explore the pharmaceutical care needs 
of, and service provision to, older people with sensory 
impairment (visual, hearing and dual impairment) on 
prescribed polypharmacy (≥4 medicines) in Scotland.
Design Interviews were conducted with older people with 
sensory impairment and community pharmacy personnel, 
which informed the content of a subsequent national 
cross-sectional survey of community pharmacists.
setting Scotland, 2015–2016.
Participants Older people with sensory impairment and 
community pharmacy personnel.
results Interviews were completed with 23 older 
people with sensory impairment (dual impairment n=13, 
visual or hearing impairment n=5 of each) and 30 
community pharmacy personnel from eight of 14 Scottish 
Health Boards. A total of 171 survey responses were 
received. Older people reported that they did not always 
disclose their sensory impairment to pharmacy personnel. 
They also reported that medicines were difficult to identify 
particularly when their name, shape or colour changed. 
Pharmacy personnel relied on visible cues such as white 
canes or guide dogs to identify visual impairment and 
suggested that hearing loss was less visible and more 
difficult to identify. Many assistive aids in support of 
medicine management, such as dosette boxes, seemed 
inadequate for complex medication regimens. Few 
community pharmacy personnel reported receiving training 
in the care of people with sensory impairment.
Conclusions This is the first comprehensive, 
multistakeholder, in-depth exploration of the 
pharmaceutical care needs of older people with sensory 
impairment. Strategies are needed to enable people 
with sensory impairment to disclose their impairment to 
pharmacy personnel (and other healthcare providers). 
Community pharmacy personnel require training to deliver 
person-centred pharmaceutical care for older people with 
sensory impairment particularly regarding communication 
with individuals in this vulnerable population.
IntrODuCtIOn 
Sensory impairment affects any age group but 
is one of the most common long-term condi-
tions of later life.1 Hearing and vision loss are 
on the increase globally and are becoming an 
important consideration as populations age.2 
Recurrent experiences of communication 
breakdown occur among people with sensory 
impairment and are associated with negative 
psychosocial well-being and reduced social 
participation activities.3–5 Older people with 
hearing, visual and dual impairment have 
higher rates of comorbidities and activity 
limitations than older people without impair-
ment.6 Additionally, the majority of individ-
uals >75 years use at least three prescribed 
medicines on a regular basis.7 This use of 
multiple medicines, also known as polyphar-
macy, is increasing as a result of the multimor-
bidity associated with an ageing population.8 
Thus, appropriate pharmaceutical care, that 
is, ‘the pharmacist’s contribution to the indi-
viduals’ care in order to optimise medicine use 
and improve health outcomes’,9 particularly 
for those with polypharmacy needs is central 
to the management of multimorbidity.8 
The United Nations Convention on the 
Rights of Persons with Disabilities,10 stipulates 
that nations ‘Provide persons with disabilities 
with the same range, quality and standard of free or 
affordable healthcare and programmes as provided 
to other persons…’. This means that people with 
sensory impairment are entitled to the same 
strengths and limitations of this study
 ► This study adopted a multiple methods approach 
with the qualitative elements providing rich data on 
the topics addressed.
 ► The low response rate to the national survey, limited 
the generalisability of the results.
 ► The nature and scope of identified barriers and fa-
cilitators to the receipt or provision of pharmaceu-
tical care were exemplified in the interviews both 
with patients and community pharmacy personnel, 
respectively.
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range, quality and standard of pharmaceutical care as well 
and that necessary accommodations have to be made.
However, little is known about the pharmaceutical care 
experiences of older people with sensory impairment. 
There is a need to be aware of patients’ needs in order 
to deliver pharmaceutical care to this vulnerable patient 
population. Difficulties have been reported in managing 
medications,6 reading labels,11 12 identifying expiration 
dates12 13 and distinguishing between different tablets.14 
Individuals with visual impairment often rely on memory 
to distinguish between medicines or on daily help to 
administer/organise their medicines,14while individuals 
with hearing impairment can struggle with the complexity 
of written medicines information.14
Few studies have explored the provision of pharmaceu-
tical care by pharmacy personnel to patients with sensory 
impairments.15 16 A recent scoping review (conducted 
by the authors of this study) identified 11 studies which 
demonstrated that people with sensory loss had lower 
levels of medication knowledge and were at higher risk of 
iatrogenic harm compared with people without sensory 
loss.16 For example, one cross-sectional survey evaluating 
practising pharmacists’ attitudes towards and methods 
of interacting with deaf patients in the USA reported 
that two-thirds of community pharmacy personnel were 
not comfortable interacting with patients with hearing 
impairment because of communication difficulties.17 
Commonly used methods for communication with indi-
viduals with hearing or visual impairment included 
hearing loops and large print resources, respectively.18
The aim of this current study was to undertake a 
comprehensive exploration of the:
 ► Pharmaceutical care needs of older people with 
sensory impairment who were receiving polypharmacy.
 ► Experiences, attitudes and training needs of commu-
nity pharmacy personnel regarding the provision of 
pharmaceutical care to this patient population.
MethODs
A multimethod approach was used comprising: semi-
structured telephone or face-to-face interviews with older 
people (depending on their preference) with sensory 
impairment on polypharmacy (hereafter referred to 
as patients); semistructured telephone interviews with 
community pharmacy personnel (ie, pharmacists, phar-
macy assistants) and a national cross-sectional survey of 
community pharmacists. The purpose of the interviews 
and survey was to characterise experiences, barriers and 
facilitators to the provision pharmaceutical care for older 
people with sensory impairments for patients with sensory 
impairment from different perspectives.
sampling and recruitment
Interviews
Older people with sensory impairment were recruited 
through different organisations including Forth Valley 
Sensory Centre, Perth Macular Society, Action on Hearing 
Loss and North East Sensory Services. The emails were 
sent on behalf of the interviewer (KK) to potential partic-
ipants by the above centres. Interested participants then 
contacted the researcher. Additionally, the study was 
advertised by Sight Action (a charity which offers support 
to blind partially sighted people in the Scottish Highlands 
and Islands) in their newsletter.
Community pharmacy personnel were recruited using 
a variety of methods. The study was advertised through 
Community Pharmacy Scotland (CPS),19 the Scottish 
national community pharmacy contractor organisation. 
Participants were also recruited at a training event which 
included a session on caring for patients with hearing 
impairment. Stratified sampling was undertaken of 
respondents to reflect geographical variation (urban and 
rural) and pharmacy type (independent, small chain, 
large multiple). Snowball recruitment20 was also used, 
that is, participants were asked to recommend other 
colleagues to participate. Informed consent was obtained 
from all participants. All interviews were conducted by a 
postdoctoral female health psychologist researcher (KK).
Topic guides (online Supplementary appendices 1 and 
2) were developed by the project team and the Project 
Advisory Group (PAG). The PAG consisted of represen-
tatives of visual and hearing impairment organisations, 
such as Action on Hearing Loss, Sight Action and Age 
Scotland and provided advice and guidance to the team 
throughout the project on research methodology and 
procedures (including the ethics application, interview 
schedules and survey development). Topic guides were 
pilot tested and no changes were required. The data 
generated from pilot interviews were included in the 
final analysis. The interviews took place between 2015 
and 2016 in Scotland. Patient interviews included explo-
ration of: their methods of managing their medicines, the 
support they received in relation to their medicines, their 
use of community pharmacies, barriers and facilitators to 
their use of medicines and community pharmacies and 
whether pharmacy personnel were aware of the patient’s 
sensory impairment. The pharmacy personnel interviews 
explored: current provision of pharmaceutical care to 
older people with sensory impairment, including barriers 
and facilitators to care provision, perceptions about medi-
cation adherence of this patient population and their 
training needs in providing pharmaceutical care to these 
patients.
Cross-sectional survey
The purpose of the survey was to explore community 
pharmacists’ experience of, and attitudes towards, the 
provision of pharmaceutical care to older patients with 
sensory impairment, as well as to identify any training 
needs in relation to the provision of care to this patient 
population. The content of the questionnaire was 
informed by the emergent themes of preliminary analysis 
of interviews with pharmacy personnel and consultation 
with the PAG. The questionnaire comprised 24 ques-
tions using Likert-type scales, multiple choice questions 
and one open-ended question. The questions captured 
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respondent demographics and explored their past and 
current experiences with providing pharmaceutical care 
to people with visual, hearing and dual impairments; 
training to cater for this patient group; perceived barriers 
and facilitators to providing pharmaceutical care and 
pharmacy facilities aimed at the needs of patients with 
sensory impairment, for example, hearing loop, Braille 
labels. In November 2016, the paper-based copy of the 
questionnaire was mailed to every community pharmacy 
(n=1186) in Scotland.
Data management and analysis
All interviews were digitally recorded, transcribed and 
anonymised. The first five interviews (of each cohort 
that is, patients, then community pharmacy personnel) 
were subjected to duplicate, independent coding to 
assess consistency and a coding framework was developed 
inductively from the data (NA and AT).21 The framework 
descriptions were finalised following discussion with the 
research team. All remaining transcripts were then coded 
by one researcher (NA) and analysed using thematic anal-
ysis22 23 in NVivo (V.11). Data saturation was achieved with 
no new themes emerging in the later interviews. Survey 
data were manually entered into SPSS V.22 and inde-
pendent, duplicate checking was performed. Descriptive 
analyses were undertaken.
Public and patient involvement
An advisory group was established which consisted of 
representatives with sight and/or hearing loss and rele-
vant patient organisations, such as Action on Hearing 
Loss, Sight Action and Age Scotland, which provided 
advice and guidance to the project team on research meth-
odology and procedures and recruitment. Their support 
was particularly useful in the development and implemen-
tation of appropriate, accessible materials and practices 
throughout the project (including the ethics application, 
interview schedules and survey development).
ethics
NHS ethical approval was not required because patients 
were not recruited through NHS organisations.
results
sample demographics
Twenty-three older people with sensory impairment took 
part in the interviews. They had been recruited from six 
Health Board areas. Fifteen interviewees were female, the 
average age was 81±8 years (range 67–95 years) and 14 lived 
alone. The majority (n=13) reported dual impairments and 
five individuals each had visual or hearing impairments, 
respectively. Interviews lasted an average of 28±11 min.
Thirty community pharmacy personnel, 17 of whom 
were pharmacists, took part in semistructured interviews. 
Just over half of (n=17) interviewees worked in inde-
pendent, single outlet pharmacies. Interviewees were 
recruited from eight of the 14 Scottish Health Boards and 
interviews lasted an average of 14±6 min.
Completed questionnaires were returned from 
171/1186 (14.4%) pharmacy personnel. Most respon-
dents (>85%) (n=143) reported providing pharmaceu-
tical care for people with visual or hearing impairment 
and 39% (n=66) reported providing care for people with 
dual impairments.
Factors affecting accessing to, and provision of, 
pharmaceutical care
A wide range of barriers (figure 1) and facilitators 
(figure 2) were identified by both types of interviewees and 
survey respondents in terms of accessing and providing 
pharmaceutical care to patients with sensory impairment. 
These factors influenced all stages of the pharmaceutical 
care journey (figure 3), that is, from the ordering or 
supply of medicines to their storage and administration, 
the most dominant of which are presented below. Any 
failure or weakness in the pharmaceutical care journey 
was associated with communication difficulties and safety 
concerns, which in turn lead to suboptimal pharmaceu-
tical care.
Figure 1 Survey respondents’ perceived barriers to 
providing care for patients with visual or hearing impairment.
Figure 2 Survey respondents’ perceived facilitators to 
providing care for patients with visual or hearing impairment.
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Ordering and accessing medicines
Older people with sensory impairments reported chal-
lenges with obtaining prescribed medicines which varied 
according to the method of ordering, that is, in person 
in the pharmacy, by phone, online or home delivery 
services. Difficulties included, patients having to make 
repeated visits to obtain their medications and waiting 
lists to receive a delivery service. Patients gave examples 
of the challenges that they encountered.
You would stand there [in the pharmacy]—has she 
seen me? Or you’ve to come back in twenty minutes 
and you’re standing there. You don’t know—have 
they got it ready, have they seen me? (ID2, Female, 
Dual impairment)
They can sometimes get confused or they won’t hear 
if you’ve shouted out their named prescription (ID26, 
Pharmacist, Multiple chain)
Pharmacy environment
Some participants with visual loss also reported that the 
layout of pharmacies was difficult to navigate.
You’ve got shelves on either side with things dis-
played on it and you’re likely to bump into that and 
send things flying onto the floor… (ID1, Male, Dual 
impairment)
Ordering online or by phone solved the problem of 
repeated visits for older people with sensory impairment, 
that is, they did not need to physically attend a pharmacy 
to order/receive their medication. One patient described 
how access to a large visual screen helped him order his 
prescription.
There must be many people again who can’t use a 
computer. I mean I’ve got a 32-inch screen I use for 
my computer (ID5, Male, Dual impairment)
However, while home delivery services helped patients 
avoid the need to travel to the pharmacy, pharmacy 
personnel were concerned that it reduced the opportu-
nity for direct communication with patients.
The other problem is even with some of the indepen-
dent pharmacies, these patients are now being cared 
for with delivery services… So it’s more the delivery 
driver who sees them… rather than the pharmacist 
(ID1, Pharmacist, Supermarket)
Communication about ordering and accessing medicines
While patients also valued the opportunity for direct 
contact with pharmacy personnel and the opportunity 
that this afforded to discuss their medicines, they also 
cited difficulties in communicating with personnel.
I’d like to see some sort of annual review at least… 
you’ve been invited for an interview with the pharma-
cist. They could go through your drug requirements 
with you (ID13, Male, Hearing loss)
People with hearing impairment reported that they did 
not always hear the full administration instructions, and 
this could be exacerbated by enunciation/accent in tele-
phone conversations.
It was the tail end of the sentence before I had 
worked out what she was talking about and I didn’t 
know which tablet she was talking about… you have a 
slight moment of panic of, am I going to have to ask 
her to repeat (ID15, Female, Hearing loss)
Pharmacy interviewees also discussed the challenges for 
communicating administration information to hearing 
impaired patients.
Three of them [patients] have quite bad hearing loss 
and they are all on polypharmacy, so it is quite diffi-
cult to communicate with any of them regarding any 
issues that comes up with their medication (ID3, Pre-
registration Pharmacist, Small chain)
I suppose with the ‘seeing ones’ [sic: meaning pa-
tients with visual impairment] it’s more you can’t re-
ally give them the patient information leaflet (ID20, 
Pharmacist, Independent)
Patients identified interventions which helped to 
improve communication including: one-to-one conver-
sations, where the individual spoke slowly and clearly 
(particularly with lip reading); use of sign language and 
the provision of written instructions (but this was not 
considered very helpful by those with visual impairment).
For patients with dual impairment, one participant 
mentioned having an interpreter and using the deaf-
blind manual.
Figure 3 Factors affecting access to/provision of 
pharmaceutical care to older people with sensory impairment.
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The other thing of course you’ve got deaf-blind man-
ual which is doing the alphabet on your hand which 
is slow but just as effective anyway (ID1, Male, Dual 
impairment)
Survey respondents perceived that difficulties in commu-
nication were a much greater barrier when providing 
care to patients with hearing impairment (>80%, n=143) 
compared with visual impairment (50%, n=87). While 
pharmacy personnel interviewees discussed hearing 
and visual impairment as separate entities, there was 
little acknowledgement of dual impairment. Where dual 
impairment was identified, there was strong reliance on 
the carer to manage patients’ medications (if they had a 
carer).
Managing and storing medicines
Inability to distinguish medicines
Patients with visual impairment reported difficulties 
when differentiating between tablets, reading instruction 
leaflets and expiry dates. The majority (70%, n=131) of 
survey respondents also cited that the changing appear-
ance of medication or packaging as a problem for patients 
with visual impairment.
It’s a bit of guess work really…I don’t read anything 
on them but there’s one packet that’s got red stripes. 
The difficulty there of course is when the pharma-
cy orders from a different drug company and it’s a 
change of packet (ID7, Female, Dual impairment)
Assistive medicine management devices
Provision of large written font on labels and Braille 
instructions on boxes helped; however, medicine labels 
were sometimes placed over Braille and large print labels 
had insufficient space for detailed instructions.
Patients reported difficulties in using monitored dosage 
systems and other packaging, such as pushing tablets out 
of foil wrapping and some described developing their 
own strategies to manage these types of storage systems.
If it’s simply a case of these little things with seven 
little boxes I can get somebody to do my own pills and 
put them in one of these (ID3, Female, Visual loss)
It was a blister pack where she pops them out and 
half of them fall onto the floor: there are no more 
tablets in the house. They are lost (ID21, Pharmacist, 
Independent)
safety concerns
Disclosure and identification of sensory impairment
A major barrier to the access and provision of care, which 
was identified, was related to disclosure by patients and/
or awareness by pharmacy personnel, of the presence 
of a sensory impairment, which may compromise safety. 
Many patients were unsure that their pharmacist was 
aware of their impairment and if they were aware, this was 
attributed to the presence of visual/physical cues such 
as a guide dog or hearing aids. Few (12%, n=21) survey 
respondents reported having a process to identify people 
with sensory impairment.
I’ve just always managed. Sometimes I wonder if my 
doctor’s practice realises I’m going blind. Sometimes 
I don’t think they’re aware of it (ID6, Male, Dual 
impairment)
It wouldn’t necessarily be obvious that somebody has 
an impairment of some description (ID20, pharma-
cist, Independent)
Survey respondents (70%, n=117) perceived that indi-
viduals with visual impairment asked for help with their 
medicines more often than individuals with hearing 
impairment (33%, n=55). The respondents had greater 
concerns (>90%, n=158) about people with visual impair-
ment managing their medicines than hearing impair-
ment (>75%, n=126).
Community pharmacy personnel described many safety 
concerns such as the wrong medicines being taken at the 
wrong time, inappropriate dose and patients’ lack of 
understanding of medicine indication and possible side 
effects. Study participants reported safety incidents which 
occurred due to communication difficulties.
They had reintroduced the 4 mg tablets and I was tak-
ing 8 (4mg) tablets a day instead of 8 (2mg) tablets so 
my blood pressure just went right down (ID5, Male, 
Dual impairment)
We had a patient, I think he is on at least 15 or 16 dif-
ferent medications. He was getting quite bad side-ef-
fects from his pain relief medication, so dizziness 
and I think he reported falling over once … it was 
quite an urgent matter and it is quite difficult getting 
all of his personal information from him (ID3, Pre-
registration Pharmacist, Small chain)
We couldn’t explain to her the need to use these ones 
carefully and not become addicted to them… I think 
maybe if she had been hearing or it was [sic, it would 
have been] easier for us to communicate (ID1, Phar-
macist, Supermarket)
Improving the quality of pharmaceutical care for patients with 
sensory impairment
Education and training
Community pharmacy interviewees and survey respondents 
reported that they had insufficient training to support the 
needs older people with sensory impairment. Few (14%, 
n=24) survey respondents reported having received training 
to support older patients with visual or hearing impairment 
(8%; n=14 for dual impairment). They reported that phar-
macy support personnel had received less training than the 
pharmacists. The majority (>80%, n=138) of respondents 
stated that they would like additional training. Pharmacy 
personnel suggested that the national Chronic Medication 
Service (during which patients’ medication is reviewed),24 
provided an opportunity to speak to patients, including 
older patients with sensory impairment, and to undertake 
medication reviews.
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One of the things we do check is… how is their vi-
sual [sic] and do they have any problems reading 
labels or getting information from leaflets (ID24, 
Pharmacist)
Assistive medicine management support
Some participants described specific approaches to 
providing pharmaceutical care for this patient popula-
tion, for example, the preparation of special medicine 
boxes and counselling at home to simplify complex 
dosing schemes. They acknowledged, however, the need 
to personalise the service provided.
But I guess the starting point with somebody with 
a sensory issue would be finding out how they 
would prefer the information (ID15, Pharmacist, 
Independent)
DIsCussIOn
This study is the first exploration of pharmaceutical care 
provision to older people with sensory impairments in the 
UK. Data were obtained from 53 interviews: older people 
with sensory impairment (23) and community pharmacy 
personnel (30) across Scotland. One in seven pharma-
cies in Scotland were represented in the survey. The key 
themes that emerged included barriers and facilitators 
in relation to ordering and accessing medicines and in 
terms of managing medicines appropriately. Non-identifi-
cation of sensory impairment or non-disclosure as well as 
various communication and accessibility challenges were 
perceived as possible safety hazards.
barriers and facilitators to accessing and providing 
pharmaceutical services
Barriers and facilitators to access and provision of pharma-
ceutical services by and for older people with sensory impair-
ment are illustrated in figures 2 and 3. These results could 
be used to improve pharmaceutical care of this patient 
population. A particular challenge identified was that a 
sensory impairment was not necessarily evident to commu-
nity pharmacy personnel and this may be further compli-
cated in that people with sensory impairment may not 
disclose vision or hearing loss. Furthermore, some patients 
indicated a preference for ordering their medicines online 
or by telephone, and this could limit the opportunities for 
community pharmacy personnel to interact/communicate 
with patients about their pharmaceutical care. Additionally, 
of the pharmacies represented in this study, few had specific 
processes to identify people with sensory impairment. This 
observation is also supported by findings of a recent study 
of pharmacists from different sectors in England.11 The 
lack of visibility of sensory impairment(s) means that the 
pharmaceutical care cannot be tailored to meet the indi-
vidual patient’s requirements. It has also been reported 
that most patients with visual impairment rely on others to 
obtain their medicines.25
safety and communication
Similar to other countries, the current quality strategy 
(Prescription for Excellence)26 in Scotland, empha-
sises the provision of safe, effective and person-centred 
pharmaceutical care to people. Our study identified 
several areas where community pharmacy personnel had 
concerns about medicine safety for older people with 
sensory impairment. Patients indicated the importance of 
informing them if a change in their medication regimens 
occurred. It would therefore be appropriate for commu-
nity pharmacy personnel to both recognise this need and 
support patients as required to identify their medicines.11
Evidence suggests that patients with hearing impair-
ment/s often do not understand the information given to 
them about their medications27 and sometimes may give 
the impression that they have understood medicine advice 
given to them.14 Pharmacists have previously indicated 
that their preferred choice of communication with this 
patient group is in writing17 but this might not reflect indi-
vidual patient’s preferences. Ideally, community pharmacy 
personnel should endeavour to provide information about 
each patient’s medicines in a format that is acceptable and 
accessible to the individual patient. Older people with 
sensory impairment might also suffer from other cogni-
tive impairments, for example, dementia.28While we did 
not assess or explore cognitive function in this study, both 
pharmacy personnel and patients reported difficulties in 
retaining medicines’ information for people with memory 
loss or dementia. These difficulties were compounded for 
people with sight loss, as they are less likely to be able to use 
written material as memory prompts.
Improving the quality of pharmaceutical care for patients with 
sensory impairment
There is a need to develop bespoke strategies to engender 
the recognition of sensory impairment by community phar-
macy personnel and disclosure by older people with sensory 
impairment. A previous multicentre study which aimed to 
measure the outcomes of a structured programme provided 
to elderly patients by community pharmacists found that 
the intervention programme had some positive effects 
on satisfaction with treatment, sign and symptom control 
and economic outcomes.29 The multicentre international 
study was performed in seven European countries. The 
intervention comprised patient assessment, formulating 
an intervention and monitoring plan for each individual 
patient. Pharmacy interventions included: (1) educating 
the patient about their drug regimen and their medical 
condition, (2) implementing compliance-improving strat-
egies such as drug reminder charts and (3) rationalising 
and simplifying drug regimens in collaboration with the 
patient’s general practitioner.
Older people also need to be empowered to ask about 
medication regimens and contribute to the develop-
ment of systems that facilitate and enable their commu-
nication between community pharmacy personnel (and 
other healthcare professionals).29 Involving patients in 
service improvement and health professional education 
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and training plays a key part in the redesign of health-
care delivery.30 Our study demonstrates the unique expe-
rience of the older person with sensory impairment and 
the need to inform future strategies to remove barriers 
and enhance accessibility, equity and quality of services.
Community pharmacy personnel need to provide 
information in suitable, alternative formats, minimise 
(where possible) and explain changes in medication 
appearance to service users, and perform regular medi-
cine reviews using a patient-centred approach to provide 
safe and effective pharmaceutical care. Future research 
needs to be targeted at creating innovative medication 
dispensing aids that reflect polypharmacy needs with 
irregular changes and adjustments in dosage. The phar-
macy environment needs to be modified and adapted 
to accommodate service users with sensory impairment. 
Ideally, modifications should be guided by design experts, 
evidence based and in collaboration with older people 
with sensory impairment.
Community pharmacy personnel identified a need for 
evidence-informed education and training in the provi-
sion of pharmaceutical care to older people with sensory 
impairment.17 Preregistration and tertiary level educa-
tion of community pharmacy personnel should include 
specific learning outcomes on safety and communica-
tion, and information about the range of assistive devices 
available to support older people with sensory impair-
ment. Those learning outcomes should be translated 
into continuing professional education requirements. 
For example, a recent collaboration between different 
stakeholders in the UK developed guidance for phar-
macy staff about the provision of pharmacy services for 
people with sight loss.15 In the USA, a Continuing Phar-
macy Education package was developed to raise pharma-
cist awareness about patients with sight impairment.31 
Further exploration is needed of role performance 
indicators.
strengths and limitations
This study used a multiple methods approach. Data satu-
ration was achieved with the interviews of service users 
and providers. The low response rate with the survey 
limited the generalisability of the results. The recruitment 
of patient participants through third parties might have 
resulted in the participation of more engaged patients. 
However, snowballing recruitment was also adopted and 
may have increased the diversity of patient participants. 
Community pharmacy personnel were recruited via the 
CPS which has almost universal coverage in Scotland.
COnClusIOns
This is the first study to explore and compare the phar-
maceutical care needs of older people with sensory 
impairment from both a service user and service provider 
perspective. This study adds to the very limited evidence 
of the provision of pharmaceutical care for older patients 
with a sensory impairment.
This patient population experiences numerous chal-
lenges throughout their pharmaceutical care journey 
and, as such, are at considerable risk of iatrogenic harm. 
Community pharmacy personnel are aware of some of 
these challenges that their patients experience but need 
support to provide person-centred, safe and effective care 
to this population particularly in terms of communication 
and safety.
This study identified patient, pharmacy and organisa-
tional factors which influence (both positively and nega-
tively) pharmaceutical care. The results will be used to 
develop and evaluate interventions through further 
research to achieve safe and effective pharmaceutical 
care for older people with sensory impairment.
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